On August 1, Baino Chuangrui (Wenzhou) Biotechnology Co., Ltd. (referred to as Chuangrui Bio) was officially recognized as a Wenzhou Innovative Small and Medium-sized Enterprise. Innovative small and medium-sized enterprises take innovation as the core, focusing on continuous exploration and optimization in multiple dimensions including products, technologies, management and business models, which reflects the enterprise’s innovation and R&D strength.

Since its establishment, Chuangrui Bio has been committed to multi-field CDMO services for biologic drugs. With the vision of building an industrial service system that underpins core innovation in China’s biomedicine sector, the company provides one-stop CDMO services for domestic and overseas biomacromolecule manufacturers and R&D enterprises, including druggability assessment, high-quality samples for early pharmacology and toxicology studies, production process development, clinical application support, clinical sample manufacturing and commercial production.